Entering text into the input field will update the search result below

Leidos, Biosortia announce immunotherapy agreement

Aug. 14, 2017 4:48 PM ETLeidos Holdings, Inc. (LDOS) StockBy: Brandy Betz, SA News Editor
  • Leidos (NYSE:LDOS) announces signing a Memorandum of Understanding with Biosortia Pharmaceuticals to focus on identifying and advancing immunotherapeutic opportunities including inmuno-oncology.
  • The companies will combine existing and future assets enabling them to deliver de-risked assets to a pharmaceutical partner for development. 
  • Leidos has various immune checkpoint inhibitor peptides and data analytics technologies that combine with Biosortia’s microbiome harvesting and mining tech.   
  • Press release       

Recommended For You

More Trending News

About LDOS Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
LDOS--
Leidos Holdings, Inc.